Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara, Eduardo A. Undurraga, Fabio Paredes et al. · New England Journal of Medicine · 2021 · 949 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 929 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

Nawal Al Kaabi, Yuntao Zhang, Shengli Xia et al. · JAMA · 2021 · 830 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Lianpan Dai, Tianyi Zheng, Kun Xu et al. · Cell · 2020 · 528 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Shilong Yang, Yan Li, Lianpan Dai et al. · The Lancet Infectious Diseases · 2021 · 454 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10